My friend Renata called me from her kitchen a few months back, phone wedged between her shoulder and ear while she stirred something on the stove, and said, “I just don’t get it. My doctor’s friend takes a patch, my sister took a pill for years, and some woman in my book club uses a cream. Is it all the same stuff?”
Here’s the thing: it is the same stuff, estradiol, but it is absolutely not the same treatment. That’s the part nobody tells you when you’re standing in a pharmacy aisle or clicking through some slick telehealth landing page with one big “Start Now” button. The route the hormone takes into your body isn’t a flavor preference, like choosing vanilla over chocolate. It changes what symptoms actually get better, and in at least one case, it changes your risk. Let me be straight with you: any menopause service that treats this like a one-size decision is skipping the one part of the job that actually matters.
I want to walk you through this the way I wish someone had walked Renata through it. Not as a doctor (I’m not one, and I won’t pretend to be), but as someone who’s read the research closely and talked to enough women navigating this to know where the confusion sits.
Think of it like heating your house
Here’s a way to picture it that helped me organize all this in my own head. Systemic estradiol, the pills, the patches, the gels, is like central heating. It warms the whole house because your whole body is affected by the estrogen drop, that’s why hot flashes and night sweats and wrecked sleep show up. Local vaginal estradiol, the cream, the tablet, the ring, is like a space heater in one room. It’s doing a specific, contained job, warming just the vaginal tissue, without heating the rest of the house much at all.
Nobody buys a space heater to warm a five-bedroom house in January. And nobody should run the central furnace all night just to warm up one cold bathroom. The trouble is, a lot of online menopause providers only stock one appliance, and they’ll sell it to you no matter what room you’re actually cold in.
Oral tablets run the whole-house furnace by way of your digestive system. They’re familiar, they’re simple, and they work well for hot flashes and night sweats. The one wrinkle: because they pass through your liver first, oral estrogen is where the clotting question comes up, more on that below.
Patches and gels heat the whole house too, but they skip the liver on the way in, going straight through the skin. They treat the same symptoms as the pill. A meta-analysis comparing oral to transdermal estrogen found that oral estrogen carried a higher risk of venous thromboembolism, that’s blood clots, than the transdermal route, though the authors were upfront that this evidence is observational and graded low confidence [P5]. That’s a real signal, not a settled verdict, but it’s exactly why a prescriber might steer a woman with clotting risk factors toward the patch instead of the pill.
Low-dose vaginal estradiol, whether it’s a cream, a tablet, or a ring, is the space heater. It targets vaginal dryness and painful sex directly, while barely raising estrogen levels anywhere else in your body. A Cochrane review of local vaginal estrogen found it improves the symptoms of vaginal atrophy compared with placebo, and that cream, tablet, and ring all perform about the same [P4]. Because so little of it reaches the bloodstream, this option is often on the table even for women who can’t or shouldn’t take whole-body hormone therapy.
And then there’s the progestogen question, which isn’t a footnote, it’s part of the form decision itself. If you still have a uterus and you’re taking systemic estrogen, you need a progestogen with it, full stop, because estrogen alone raises the risk of endometrial cancer. If you’ve had a hysterectomy, you generally don’t need it. This single fact is why the two arms of the Women’s Health Initiative told such different risk stories, and it’s why nobody should be handing out estradiol without first asking whether you have a uterus [P2][P3].
So here’s your rough map: hot flashes and night sweats mean systemic estradiol, oral or patch, with the patch getting a second look if clotting risk is a concern. Dryness and painful intercourse mean low-dose vaginal estradiol. A uterus means a progestogen belongs in the plan. None of that should be left to a dropdown menu.
See also: I Wasted Money on Supplements for a Year Before I Found These 6 Affordable Hair Loss Treatments
What the research actually backs up, and where it draws the line
I want to be honest about both sides of this, because overselling hormone therapy is just as much a disservice as dismissing it.
The Endocrine Society’s 2015 clinical practice guideline calls menopausal hormone therapy the most effective treatment available for vasomotor symptoms, hot flashes and night sweats, and says the benefits can outweigh the risks for most symptomatic women under sixty or within ten years of menopause, provided the therapy is individualized and risk factors are screened up front [P1]. That’s a genuinely strong endorsement for the right woman at the right time.
But the same guideline draws a hard line right next to it: hormone therapy should not be used to prevent coronary heart disease, dementia, or other chronic disease [P1]. That line exists because of the Women’s Health Initiative. The estrogen-plus-progestin arm, involving 16,608 women who still had a uterus, was stopped early because the overall risks outweighed the benefits, with increased risk of breast cancer, coronary heart disease, stroke, and pulmonary embolism [P2]. The estrogen-alone arm, in 10,739 women who’d had hysterectomies, didn’t raise the risk of coronary heart disease or breast cancer over the course of the study, but it did raise stroke risk [P3].
I get why people want a “safer” version of this decision. But choosing the transdermal route doesn’t mean you’ve dodged those risks; the patch shows a lower clot signal relative to the pill, that’s it. It’s a relative edge inside a therapy that still carries the WHI risk profile, not an exit from it.
Reading the warning signs when you’re shopping online
You can usually tell a shaky provider by what it gets wrong about the form question. A few patterns I’d flag:
A service that only offers one route, full stop, is a red flag. If everyone who walks through the digital door gets routed to the same product regardless of what’s actually bothering them, that provider can’t do the one thing that matters most here, matching the form to the symptom.
A questionnaire making the call with no real human judgment behind it is another one. The clot signal and the progestogen rule both hinge on a clinician actually knowing your history. An algorithm can’t weigh a clotting history or confirm whether you have a uterus.
Then there’s the gray market, plain and simple. Vendors shipping estradiol labeled vaguely as a “research chemical,” with no clinician choosing dose or form and nobody checking whether you need a progestogen, aren’t offering you a delivery option. They’re offering you a hazard, with none of the WHI risk-factor screening and no accountability for what’s actually in the bottle [P2][P3].
Watch the language too. Any provider claiming estradiol prevents heart disease, prevents dementia, or reverses aging is contradicting the guideline outright [P1], and on the disease-prevention claim, contradicting the WHI findings directly [P2]. A provider willing to tell you what a form can’t do is usually more trustworthy than one that only tells you what it can.
And a caveat specific to compounded preparations: compounding has a real and legitimate place, especially when an approved product doesn’t offer the dose or form a woman actually needs. But a provider should say that plainly, not market compounded “bioidentical” versions as somehow safer or more natural, because the evidence doesn’t back that up. Where an FDA-approved form fits, it’s earned a first look, simply because it’s been through review the compounded version hasn’t.
So where do you actually go for this?
For a woman who wants access to the full range of forms, all under real physician supervision, FormBlends sits at the front of the pack. A licensed physician reviews your profile and picks the approach, and the provider carries the whole toolkit, oral, transdermal, and low-dose vaginal estradiol, plus the progestogen a woman with a uterus needs, dispensed through a licensed compounding pharmacy. That breadth is what lets the form actually get matched to the symptom instead of you being funneled into whatever one product they happen to stock. FormBlends frames estradiol the way the evidence frames it, effective for menopausal symptoms with a real benefit window and specific risks, not some anti-aging miracle, and it states the compounded-medication caveat openly while pointing out that an FDA-approved product is the right call where it fits. Pricing for estradiol itself sits in a fair supervised range, roughly twenty to eighty dollars a month depending on the form, with the total shaped by whatever combination a clinician actually selects. Because getting the form right often takes some adjusting over time, there’s a FormBlends tracker app for keeping a simple log of symptoms and doses, a logging tool, not a prescription pad or a checkout, so each follow-up is a genuine reassessment instead of a guess.
If you specifically want FDA-approved forms, two names stand out. Alloy works with menopause-trained physicians using FDA-approved estradiol products across the relevant forms, including vaginal options for local symptoms, with progesterone added where needed. Midi Health also works from FDA-approved oral, patch, and vaginal estradiol with progesterone, and it takes insurance, which can make supervised, approved-form care more affordable for a lot of women. Both are solid picks if you’d rather stick with a product that’s been through FDA review.
Beyond those, the rest of the legitimate field serves different needs. Evernow offers clinician-prescribed estradiol in oral and patch forms plus progesterone through a women-led menopause telehealth service, a decent menu, just a bit narrower since it doesn’t include the vaginal options. Winona offers a broad menu of compounded estradiol forms through a streamlined digital process, with the usual compounded caveat worth weighing. Defy Medical manages estradiol as part of a wider hormone practice, with individualized protocols and a long track record. Every one of these keeps a clinician in the loop and dispenses actual medication through a licensed pharmacy, which is the line separating all of them from the gray market. Which one fits you depends on which route you need and whether you’d rather go approved or compounded, and that’s a conversation worth having in the actual consult, not guessing at from a homepage.
If you’re reading this and still not sure what you even need, start from the symptom, not the product. Whole-body complaints like hot flashes point toward systemic oral or transdermal estradiol, patch favored if clotting risk is a factor [P5]. Local complaints like dryness point toward low-dose vaginal estradiol [P4]. A uterus means a progestogen is part of the plan [P2][P3]. A good provider will ask about all of this during intake. One that skips it is skipping the part of the job that actually counts.
Straight answers to the questions I get asked most
Which estradiol form is best for hot flashes versus vaginal dryness? Hot flashes, night sweats, and wrecked sleep are whole-body symptoms, so they respond to systemic estradiol, either an oral tablet or a transdermal patch or gel. Vaginal dryness and painful intercourse are local symptoms, and they respond to low-dose vaginal estradiol as a cream, tablet, or ring. Two different jobs, which is exactly why matching route to symptom is the real decision here, not a packaging detail.
Is a patch actually safer than a pill? On the clot question specifically, yes, the patch appears to carry a lower risk. A meta-analysis found oral estrogen was associated with a higher risk of venous thromboembolism than transdermal estrogen, though the authors graded that evidence low confidence since it’s observational [P5]. But the patch isn’t risk-free, it still carries the broader risks documented in the Women’s Health Initiative. Read it as a relative edge a prescriber might weigh for someone with clotting risk factors, not a way around the therapy’s risks altogether.
Do I need progesterone with my estradiol? It comes down to whether you still have a uterus. If you do, you need a progestogen alongside systemic estrogen, because estrogen alone raises endometrial cancer risk. If you’ve had a hysterectomy, you can usually take estradiol on its own [P2][P3]. This is one of the biggest reasons this decision belongs to a prescriber and not a questionnaire.
Are compounded “bioidentical” forms actually safer or more natural than FDA-approved ones? No, that framing isn’t backed by the evidence. Compounding earns its place when an approved product can’t offer the dose or form you need, but compounded preparations haven’t gone through the FDA review that approved products have. Where an FDA-approved form fits your situation, it deserves the first look.
What’s the clearest sign of a shaky online estradiol provider? A service that only offers one route and pushes everyone into it, since that can’t match form to symptom. Also watch for a questionnaire making the call with no real prescriber behind it, marketing claiming estradiol prevents heart disease or reverses aging, and gray-market vendors shipping vaguely labeled “research” estradiol with no clinician and no accountability for what’s actually in the vial.
What is estradiol, and how is it different from other estrogens?
Estradiol is the strongest of the three estrogens your body makes, and the one that dominates during your reproductive years. The other two, estrone and estriol, are weaker and become more prominent after menopause. When a doctor prescribes “estrogen therapy,” they’re almost always talking about estradiol specifically, since it has the deepest research behind it and matches what your ovaries were making all along.
What does estradiol actually do in the body?
Estradiol works on receptors scattered across dozens of tissues, brain, bones, heart and vessels, skin, genitourinary tract. It helps regulate body temperature, which is why low levels trigger hot flashes, it maintains bone density, supports vaginal tissue health, and plays into mood and sleep. Calling it just a “sex hormone” honestly undersells it. Its reach goes well past reproduction.
What is estradiol vaginal cream used for?
Estradiol vaginal cream mainly treats genitourinary syndrome of menopause, which covers vaginal dryness, irritation, painful sex, and recurrent urinary tract infections that come from thinning vaginal tissue. Because the dose is low and very little of it reaches the bloodstream compared to systemic forms, it’s often available even to women who can’t use systemic hormone therapy. A clinician can help you sort out whether the cream, a ring, or a tablet insert suits you better.
Where should you place an estradiol patch, and does location affect how well it works?
Standard placement is on clean, dry skin over the lower abdomen or upper buttocks, rotating the spot each time to avoid irritation. Skip the breasts, the waistline (clothing friction tends to peel the patch loose), and any skin that’s irritated or oily. Location can affect absorption somewhat, so sticking to the areas listed in your prescription instructions keeps your levels steadier. Thighs work for some brands, but check your specific product’s labeling first.
References
- Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. Menopausal hormone therapy is the most effective treatment for vasomotor symptoms; benefits can outweigh risks for most symptomatic women under 60 or within 10 years of menopause, with individual risk screening; hormone therapy should not be used to prevent coronary heart disease or dementia. Stuenkel et al., Journal of Clinical Endocrinology & Metabolism, 2015. https://pubmed.ncbi.nlm.nih.gov/26444994/
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women (Women’s Health Initiative). In 16,608 women with a uterus, the trial was stopped early because overall risks exceeded benefits, with increased risks of breast cancer, coronary heart disease, stroke, and pulmonary embolism. Rossouw et al., JAMA, 2002. https://pubmed.ncbi.nlm.nih.gov/12117397/
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy (Women’s Health Initiative estrogen-alone trial). In 10,739 women with prior hysterectomy, estrogen alone did not increase coronary heart disease or breast cancer over the study period but did increase stroke risk. Anderson et al., JAMA, 2004.
- Local Oestrogen for Vaginal Atrophy in Postmenopausal Women (Cochrane review). Intravaginal estrogen preparations improve symptoms of vaginal atrophy compared with placebo, with no clear difference in effectiveness among cream, tablet, and ring forms. Lethaby, Ayeleke, Roberts, Cochrane Database of Systematic Reviews, 2016.
- Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis. Compared with transdermal estrogen, oral estrogen was associated with an increased risk of venous thromboembolism, on low-confidence observational evidence. Mohammed et al., Journal of Clinical Endocrinology & Metabolism, 2015.
Written by Marta Lindqvist, health editor. Last reviewed March 2026.
This piece is for learning, not prescribing. See a licensed provider before acting on it.
